Vote Scores

Home / Companies / Spero Therapeutics, Inc. / 5 Oct 2023

Meeting · year to 30 June 202475 filers reporting

Spero Therapeutics, Inc.: meeting of 5 Oct 2023

Votes reported on Form N-PX, item by item

75 Form N-PX filers reported votes at the Spero Therapeutics, Inc. meeting of 5 Oct 2023. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 74.6% of reported votes for; 9 filers withheld from or voted against at least one nominee.

63 vote records from 16 filers. 2 of the 16 filers that marked the item either way voted against management.

87.5% for0.0% against12.5% other12.5% against management16 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

83 vote records from 72 filers. 11 of the 69 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided

80.6% for15.3% against4.2% other15.9% against management72 filers94.8% for5.2% against5.2% against management8,705,214 reported shares
3

SECTION 14A SAY-ON-PAY VOTESIssuer

Frequency of the say-on-pay vote

one year: 62 filers; three years: 5 filers; shares year 1: 1 filer; : 1 filer; for: 1 filer; not applicable: 1 filer.

83 vote records from 72 filers. 5 of the 68 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.

One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided

1.4% for0.0% against98.6% other7.4% against management72 filers0.0% for0.0% against100.0% other1.0% against management7,263,657 reported shares
4

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

21 vote records from 16 filers. 0 of the 16 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management16 filers100.0% for0.0% against0.0% against management1,902,187 reported shares
5

SHAREHOLDER RIGHTS AND DEFENSESIssuer

SHAREHOLDER RIGHTS AND DEFENSES: management items

Management items in this category are shown together; filers word and number them differently.

18 vote records from 13 filers. 0 of the 13 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management13 filers100.0% for0.0% against0.0% against management1,862,996 reported shares, counted once per item in this group
6

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

26 vote records from 19 filers. 3 of the 19 filers that marked the item either way voted against management.

84.2% for15.8% against15.8% against management19 filers81.5% for18.4% against0.0% other18.4% against management1,909,057 reported shares, counted once per item in this group
7

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

24 vote records from 16 filers. 1 of the 16 filers that marked the item either way voted against management.

93.8% for6.3% against6.3% against management16 filers97.1% for2.9% against2.9% against management1,941,378 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Pay-vote frequency4. Auditor
VanguardForForSplit or no voteFor
BlackRock and iSharesForForSplit or no voteFor
FidelityForForSplit or no voteFor
DimensionalAbstain or withhold *Against *Split or no vote *For
State Street and SPDRNo reportForSplit or no voteNo report
American CenturyForForSplit or no voteFor
Franklin TempletonForForSplit or no voteFor
EquitableForForSplit or no voteFor
Charles SchwabForForSplit or no voteFor
John Hancock and ManulifeForForSplit or no voteFor
Morgan Stanley, Eaton Vance and CalvertNo reportForSplit or no voteNo report
Goldman SachsNo reportSplit or no voteSplit or no voteNo report
PGIM and PrudentialNo reportAgainst *Split or no voteNo report
Jackson National fundsAbstain or withhold *Against *Split or no vote *For
Northern Trust and FlexSharesForForSplit or no voteFor
Victory CapitalForForSplit or no voteFor
Guggenheim and RydexForForSplit or no voteFor
Columbia ThreadneedleNo reportAgainst *Split or no voteNo report
BNY MellonNo reportForSplit or no voteNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Spero Therapeutics, Inc. meeting?

75 Form N-PX filers reported votes at the meeting of 5 Oct 2023. On say-on-pay, 11 of 69 voted against management (15.9%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Spero Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Spero Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Spero Therapeutics, Inc. with a meeting date within three days of 5 Oct 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.